Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,509 | 225 | 81.4% |
| Travel and Lodging | $839.20 | 5 | 15.2% |
| Education | $188.90 | 9 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $1,187 | 14 | $0 (2024) |
| AbbVie Inc. | $838.67 | 44 | $0 (2023) |
| Novo Nordisk Inc | $433.58 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $313.92 | 12 | $0 (2024) |
| Exeltis, USA Inc. | $271.69 | 4 | $0 (2022) |
| Agile Therapeutics, Inc. | $229.58 | 13 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $209.18 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $161.77 | 9 | $0 (2024) |
| Allergan, Inc. | $153.71 | 15 | $0 (2020) |
| Myovant Sciences Inc. | $148.82 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.90 | 36 | Astellas Pharma US Inc ($201.90) |
| 2023 | $1,635 | 40 | Intuitive Surgical, Inc. ($1,018) |
| 2022 | $778.82 | 42 | ABBVIE INC. ($196.14) |
| 2021 | $946.82 | 40 | AbbVie Inc. ($221.18) |
| 2020 | $178.83 | 10 | AbbVie Inc. ($94.40) |
| 2019 | $417.10 | 31 | AbbVie, Inc. ($154.25) |
| 2018 | $425.90 | 23 | AMAG Pharmaceuticals, Inc. ($158.49) |
| 2017 | $239.53 | 17 | Novo Nordisk Inc ($72.43) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Biological | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Biological | ||||||
| 08/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Hyperkalemia | ||||||
| 08/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: HORMONE THERAPY | ||||||
| 07/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Biological | ||||||
| 07/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Hematology | ||||||
| 07/10/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Hyperkalemia | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/16/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: HORMONE THERAPY | ||||||
| 05/09/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 05/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Hyperkalemia | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Biological | ||||||
| 04/19/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 04/17/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 04/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Obesity | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $77.36 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 187 | 207 | $14,762 | $10,986 |
| 2022 | 5 | 186 | 209 | $14,472 | $11,306 |
| 2021 | 6 | 205 | 241 | $17,449 | $13,939 |
| 2020 | 7 | 189 | 236 | $16,750 | $12,659 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 52 | $5,068 | $3,604 | 71.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 50 | 50 | $2,516 | $2,068 | 82.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 49 | 49 | $1,666 | $1,632 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,251 | $1,423 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 29 | $1,884 | $1,269 | 67.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 11 | 12 | $1,378 | $990.44 | 71.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 61 | $5,945 | $4,295 | 72.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 55 | 55 | $2,767 | $2,322 | 83.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $2,623 | $2,039 | 77.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 56 | 56 | $1,903 | $1,881 | 98.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 19 | $1,234 | $768.48 | 62.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 60 | $5,848 | $4,372 | 74.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 49 | $3,183 | $2,382 | 74.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 50 | 50 | $2,516 | $2,138 | 85.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $2,251 | $1,787 | 79.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 50 | 50 | $1,700 | $1,700 | 100.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 16 | 17 | $1,952 | $1,562 | 80.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 83 | $5,391 | $3,941 | 73.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 34 | $3,314 | $2,250 | 67.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 41 | 41 | $2,063 | $1,738 | 84.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $1,951 | $1,489 | 76.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 40 | 40 | $1,360 | $1,356 | 99.7% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 12 | 14 | $1,608 | $1,200 | 74.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $1,064 | $685.47 | 64.4% |
About Dr. Robert Smith, M.D
Dr. Robert Smith, M.D is a Obstetrics & Gynecology healthcare provider based in New Port Richey, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457370884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Smith, M.D has received a total of $5,537 in payments from pharmaceutical and medical device companies, with $915.90 received in 2024. These payments were reported across 239 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,509).
As a Medicare-enrolled provider, Smith has provided services to 767 Medicare beneficiaries, totaling 893 services with total Medicare billing of $48,890. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location New Port Richey, FL
- Active Since 07/18/2006
- Last Updated 12/14/2015
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457370884
Products in Payments
- Da Vinci Surgical System (Device) $1,187
- LO LOESTRIN FE (Drug) $378.78
- SLYND (Drug) $238.55
- Twirla (Drug) $229.58
- ORILISSA (Drug) $228.40
- INTRAROSA (Drug) $217.39
- MYFEMBREE (Drug) $196.59
- Veozah (Drug) $196.04
- Orilissa (Drug) $189.69
- XARELTO (Drug) $149.13
- XIFAXAN (Drug) $140.12
- Rybelsus (Drug) $138.73
- Xulane (Drug) $132.26
- Kerendia (Drug) $121.63
- Victoza (Drug) $107.68
- ORIAHNN (Drug) $100.06
- Ozempic (Drug) $94.00
- MEDLINE INDUSTRIES, INC. (Device) $81.46
- Veltassa (Drug) $75.39
- EMGALITY (Drug) $74.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in New Port Richey
Dr. Jessica Stine, M.d, M.D
Obstetrics & Gynecology — Payments: $144,740
Dr. Thomas Umstead, Md, MD
Obstetrics & Gynecology — Payments: $2,095
Lenore Cappelluti, Msn,Rn,Apn-C, MSN,RN,APN-C
Obstetrics & Gynecology — Payments: $470.62
Dr. Melchiades Loman, M.d, M.D
Obstetrics & Gynecology — Payments: $306.10
Dr. Charles Suggs, Md, MD
Obstetrics & Gynecology — Payments: $157.04